ACR was recently awarded a $7M grant to address inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant is supported by the Centers for Disease Control and Prevention CDC) and will be led by…
September is Rheumatic Disease Awareness Month (RDAM). Georgia State Representative, Kim Scofield shares her story of living with lupus and brings encouragement to us all! Read Kim's RDAM Patient Spotlight Blog>
ACR's Lupus Initiative is a multi-faceted education program designed to reduce disparities and improve outcomes among people with lupus through the development and dissemination of evidence-based educational resources for health care providers. The development of lupus educational materials relies on…
See important information about in-person meeting cancellations related to COVID-19 as well brief answers to some frequently asked questions. Learn more.
Doctors and healthcare providers can provide these online self-management resources and tools to people living with lupus and lupus nephritis to assist with self-managing the disease.
The 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology Classification (ACR) Criteria for Systemic Lupus Erythematosus (SLE) available here.
The ACR Collaborative Initiatives (COIN) department invites letters of interest from members wishing to help develop educational training for PCPs, NPs and PAs on Osteoarthritis. SUBMISSION DEADLINE: Thursday January 31, 2019 Working Group to Improve Provider Team Education on Osteoarthritis…
LUPUS IS NOT A ZEBRA The likelihood that your symptomatic patient has lupus increases based on gender, race, ethnicity, and age. In which case, lupus is not a zebra. It’s a horse. Know when to suspect lupus. Know when to…
The Lupus Initiative is excited to launch The Playbook Project! This localized grassroots lupus awareness campaign initiative provides turnkey grassroots activities to student organizations at four-year colleges and universities in a step by step implementation guide called, The Playbook. Student…
ACR Collaborative Initiatives is featured in the May 2018 issue of The Rheumatologist. The article titled "The ACR's COIN Department Connects Providers with Communities" is featured in the President's Perspective column and was written by ACR President, David I. Daikh,…
ACR's Collaborative Initiatives department is proud to share the following interviews featuring members of our MIMICT Advisory Committee. Committee Member, Dr. Priscilla Pemu recently sat down with Atlanta's local NPR station, WABE, to discuss "Reconciling Distrust in Clinical Research" in a special…
The ACR Collaborative Initiatives department (COIN) is honored to be a recipient of the 2018 American Society of Association Executives (ASAE) Innovation Grants Program (IGP). COIN will be recognized during ASAE's 2018 Great Ideas Conference, March 11-13 in Colorado Springs, CO.…
The Be Fierce. Take Control.TM lupus awareness campaign, is featured in the January 2018 issue of The Rheumatologist. Be Fierce. Take Control.TM was jointly created by the ACR and the Lupus Foundation of America (LFA) and launched in June 2018. The campaign…
The Ohio State University Wexner Medical Center in Columbus will open its second multi-disciplinary lupus clinic later this year. Multi-disciplinary lupus clinics provide patients with broader access to a variety specialists in one location. READ FULL ARTICLE
The ACR Lupus Initiative (TLI) offers the following complimentary lupus teaching tools and educational resources to medical and health professional schools: Interactive Case Studies Traditional Case Studies PowerPoint Slides Short Teaching Videos Request access here >>
"Living with Lupus," featuring Shanelle Gabriel Shanelle shares her journey and provides inspiration for others living with Lupus through our Simple Tasks campaign patient documentary.
Led by a passion to improve the clinical reasoning skills of future doctors, Maria Dall’Era, MD, Associate Professor of Medicine and Director of the University of California San Francisco (UCSF) Lupus Clinic is taking the PIVOT project to the next…
The Lupus Initiative is saddened to learn of the passing of Evelyn V. Hess, MD, former ACR master member, distinguished professor emerita, founder and former chief of the division of immunology, allergy, and rheumatology at the University of Cincinnati Medical School. Over…
The American College of Rheumatology's Lupus Initiative announced the award of a one-year $500,000 grant from the Office of Minority Health. Read the full press release here.
The Lupus Initiative’s® (TLI) project entitled, Teaching Fellows in Lupus, was presented at the 2015 ACR/ARHP Annual Meeting, November 6-11, 2015 in San Francisco. Teaching Fellows in Lupus aims to reduce health disparities in lupus by increasing awareness and knowledge of the disease…
An abstract on The Lupus Initiative’s® (TLI) project: Practice Improvement Using Virtual Online Training (PIVOT), has been accepted for a poster presentation at the American College of Rheumatology’s annual meeting, November 6-11, 2015 in San Francisco. PIVOT, a medical evaluation…
Excerpted from The Rheumatologist, August 17, 2015. The ACR’s Lupus Initiative Expands Training, Educational Resources By E. William St.Clair, MD The Lupus Initiative (TLI) has been an emergent creation inside the American College of Rheumatology (ACR) for the past six…
Advancing Rheumatology! may mean different things to the varied membership of the ACR. This is in part because the ACR is expected to do many things for many people, and I believe we do many things exceptionally well. I hope…
Did you know that the subject of lupus is often given only 15 minutes in the medical school curriculum? That’s why we were so excited about the recent launch of The Lupus Initiative, a federally funded lupus education program for…
Excerpted from FDA News Release, dated March 9, 2011 The US Food and Drug Administration (FDA) approved Benlysta (belimumab) for the treatment of lupus patients with active autoantibody- positive systemic lupus erythematosus (SLE). The last drugs to receive FDA approval…
